Earnings Ahead

PFE - Pfizer

29.47 0.38 1.31

  1. Home
  2. Healthcare
  3. PFE
Pfizer

Pfizer

About

Profile

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Headquarters

New York City, New York, United States

Intraday

High
-
Low
-

52-week

High
-
Low
-

PFE



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • How Pfizer can compete in the obesity space with its Metsera acquisition
  • Biggest stock movers Monday: Crypto stocks, MTSR, ODP, and more
  • 4 stocks to watch on Monday: PFE, KO, STLA, ORCL
  • M&A Snapshot: Pfizer expands obesity pipeline with Metsera buy, adding 4 clinical programs
  • Pfizer to acquire Metsera for $47.50/share in $4.9 billion deal
  • Trump considering website for consumers to buy discounted prescription drugs - report
  • CDC vaccines panel votes unanimously to change COVID-19 vaccine recommendation
  • CDC vaccines panel head Kulldorff challenges former directors to debate
  • New York issues its own COVID-19 vaccine guidance
  • Arvinas, Pfizer to outlicense commercialization of cancer asset vepdegestrant
  • West Coast states issue own vaccine guidance citing “politicization of science” under Trump
  • U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting
  • Former CDC Director Monarez says RFK Jr. fired her for not following two directives
  • Roivant and Pfizer-backed Priovant post late-stage trial win for dermatomyositis therapy
  • Pfizer, Moderna post data supporting COVID shots after Trump demand
  • Five new members added to CDC vaccine advisory panel
  • Former Trump surgeon general says RFK Jr. must go
  • COVID vaccine names take a hit after report of child deaths in CDC presentation
  • Market Voices: Kenvue vs. RFK Jr., COVID shot safety, Lendbuzz IPO
  • CDC to offer contract to study link between vaccines and autism

Earnings History

Date EPS / Forecast Revenue / Forecast
February 8, 2022 1.08 / 0.8742 23.84B / 24.16B
November 2, 2021 1.34 / 1.08 24.09B / 22.58B Beat!
July 28, 2021 1.07 / 0.9705 18.98B / 18.71B Beat!
May 4, 2021 0.93 / 0.7759 14.58B / 13.65B Beat!
February 2, 2021 0.42 / 0.4952 11.68B / 11.47B Beat!
October 27, 2020 0.72 / 0.7139 12.13B / 12.31B
August 4, 2020 - / 0.68 - / 11.67B
April 28, 2020 0.8 / 0.73 12.03B / 11.81B Beat!
January 28, 2020 0.55 / 0.58 12.69B / 12.61B Beat!
October 29, 2019 0.75 / 0.62 12.68B / 12.26B Beat!
July 29, 2019 0.8 / 0.75 13.26B / 13.4B
April 30, 2019 0.85 / 0.75 13.12B / 12.99B Beat!
January 29, 2019 0.64 / 0.63 13.98B / 13.9B Beat!
October 30, 2018 0.78 / 0.75 13.3B / 13.5B
July 31, 2018 0.81 / 0.74 13.47B / 13.31B Beat!
May 1, 2018 0.77 / 0.74 12.91B / 13.14B
January 30, 2018 0.62 / 0.56 13.70B / 13,684M
October 31, 2017 0.67 / 0.64 12.90B / 13,175M
August 1, 2017 0.67 / 0.66 12.78B / 13,081M
May 2, 2017 0.69 / 0.67 12.78B / 13,080M